A Study to Evaluate the Safety and Effectiveness of Ustekinumab or Golimumab Administered Subcutaneously (SC) in Patients With Sarcoidosis
Clinical trial NCT00955279 · COMPLETED
Trial details
- NCT number
- NCT00955279
- Sponsor
- Centocor, Inc.
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2009-11-01
- Primary completion
- 2012-05-01
- Enrollment
- 173
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.